Small-Cap Value Funds 

Investing in the stock market can be exhilarating and intimidating at the same time. One of many options available today is some small-cap value funds, which have gained much attention as capable delivery vehicles for tremendous returns. This guide comprehensively explains small-cap value funds, their performance dynamics, associated risks, investment strategies, and more. By the end, you will be well-equipped to make informed decisions regarding small-cap value funds. 

What Are Small-Cap Value Funds? 

Small-cap value funds are equity mutual funds or exchange-traded funds (ETFs) focused on the stocks of undervalued small-size companies. The companies concerned trade at low price-book (P/B), low price-earnings ratio (P/E), and price-cash flow ratio (P/CF), making them an excellent investment opportunity for capitalising on future growth and market corrections. 

What Are Small-Cap Value Stocks? 

The market capitalisation of companies associated with smaller-cap stocks would range from USD 300 million to USD 2 billion. Value also means the stock’s price is lower than the calculated intrinsic value derived from other financial metrics, such as earnings, assets, or cash flow. 

Important Characteristics 

  1. Market Capitalisation:

Small-cap companies are largely at the lower ranks. They are mainly in the growth stage and also have room for growth. 

  1. Value Metrics:

“Value” refers to how these companies trade cheaper at their estimated intrinsic values than the market values. 

Valuation metrics involved  

  • Low P/B ratios  
  • P/E ratios  
  • In high dividend yields in some cases 
  1. Growth Potential:

Many small-cap value stocks are in industries or sectors that have growth prospects but are experiencing cyclical headwinds that temporarily make the investment less appealing to investors. However, these stocks provide value to long-term investors. 

  1. Risk and Volatility:

Small-cap value funds are more volatile than large-cap funds because the underlying companies are relatively small and hence easily susceptible to market conditions. 

Understanding Small-Cap Value Funds 

To understand small-cap value funds, it is essential to understand their makeup, the companies they focus on, and how fund managers work. 

Investment Universe 

Small-cap value funds primarily target companies showing these characteristics: 

  • Lower Market Valuations: Stocks trading at a discount relative to their intrinsic value. 
  • Growth Potential: Businesses showing promise in future earnings and market potential. 
  • Financial Resilience: Businesses with sound fundamentals, despite market mispricing. 
  • Undervalued Sectors: Often, these funds invest in sectors experiencing temporary downturns but with a positive long-term outlook. 

Fund Manager Strategies 

Fund managers play a pivotal role in identifying suitable small-cap value stocks. Their strategies often involve: 

  • Thorough Financial Analysis: Examining a company’s health through profitability and growth metrics. 
  • Industry Trends: Identifying sector-specific trends that may drive the stocks. 
  • Valuation Techniques: Using fundamental analysis to find those stocks selling below their true value. 
  • Diversification: Spreading investments across different sectors and industries to mitigate risks. 
  • Active or Passive Management: Some funds are actively managed, while others track a small-cap value index. 

Performance and Risk of Small-Cap Value Funds 

Historical Performance Trends 

Historically, small-cap value funds have shown the possibility of beating other asset classes for long-term returns. Using financial data, it’s clear that small-cap value stocks in the US stock market have offered much more solid returns than large-cap and growth stocks during some periods.  

As examples: 

  • 5-Year Average Return: Approximately 11%–15% every year, depending on which fund and market condition has prevailed. 
  • 1-Year Returns (2023): Some funds have reported more than 30% yields because of market recoveries and undervalued opportunities. 

It is worth noting that although the performance of small-cap value funds in the past has been encouraging, past results alone are not a predictor of future performance. 

Risk Considerations  

Investing in small-cap value funds has natural risks, such as the following: 

  1. Market Volatility: Small-cap stocks are more volatile than large-cap stocks, which means that price swings are increasing.
  2. Economic Sensitivity: These equities are generally more sensitive to macroeconomic factors.
  3. Liquidity Risk: Small firms’ low trading volumes result in lower market liquidity, which increases the prospect of price impact during a purchase or sale.
  4. Company-Specific Risks: Bad management, debt, and operational problems are some of the factors that can seriously affect small-cap companies. Before investing capital, these risks must be compared with investment goals and time horizons.

Investment Strategies in Small-Cap Value Funds 

  1. Long-Term Investment Horizon

Small-cap value stocks may also require some time to see their real market value. An indicative holding period of 5–10 years will also help these companies grow, recover from temporary failure, and get maximum returns. 

  1. Diversification

The diversification in small-cap value funds will act as an important tool of risk management. Diversified funds invest in several sectors and industries to ensure that the failure of the stocks does not have a strong effect on the fund. 

  1. Active Monitoring

Small-cap value funds should periodically be reviewed to ensure proper performance. Investors, too, must be well-equipped with market conditions to identify assets or sectors that may not perform and make strategic adjustments in those areas. 

  1. Dollar-Cost Averaging

The fixed amount invested periodically will reduce the impact of market volatility. The strategy will ensure the purchase of more shares at lower prices and fewer at higher prices, which will average the cost in the long run. 

Examples of Small-Cap Value Funds 

Several well-reputed small-cap value funds exist, especially in developed markets like the United States. Below are some examples of small-cap value funds, with their unique strategies, performance, and benefits to investors. 

  1. Vanguard Small-Cap Value Index Fund (VSIAX)

It is a favourite investment option for those who want to access a diversified portfolio of small-cap value stocks. The fund tracks the CRSP US Small-Cap Value Index, which contains a wide range of undervalued companies across all sectors. 

Key features 

  • Low Expense Ratio: The expense ratio of the Vanguard Small-Cap Value Index Fund is extremely low, at 0.07%. This makes it one of the ideal choices for long-term investors seeking minimal investment costs. 
  • Diversification: The fund invests in hundreds of small-cap stocks, providing broad market exposure while minimising the risks associated with individual stock performance. 
  • Performance: The fund has historically delivered consistent returns aligned with the overall small-cap value segment and outperformed many actively managed alternatives over extended periods. 

This fund appeals to passive investors who care more about low costs and broad exposure to small-cap value stocks. Hence, it can be used as a cornerstone for diversifying portfolios. 

  1. Dimensional U.S. Targeted Value Portfolio (DFFVX)

Dimensional Fund Advisors runs an actively managed fund with a target of small-cap value stocks with high profitability. This follows the use of stringent filters that look for companies that, at attractive valuations, show a solid base. 

Key Features 

  • Active Management: The fund has active management, and the managers can spot specific opportunities and react to any changes in market conditions. 
  • High-quality metrics: The portfolio’s investments are based on strong profitability metrics, which act as a buffer to balance the intrinsic risks within small-cap investing. 
  • Expense Ratio: Although higher than index funds, the expense ratio of around 0.44% is competitive for an actively managed fund. 

This fund is ideal for investors who want a more hands-on approach to small-cap value investing, with a chance of higher returns because of strategic stock selection. 

  1. TIAA-CREF Small-Cap Blend Index Fund (TISBX)

The TIAA-CREF Small-Cap Blend Index Fund tracks the Russell 2000 index and combines the features of small-cap value and growth stocks, thus giving exposure to a mix of the best value and growth stock opportunities in the small-cap universe. 

Key Features 

  • Broad Exposure: This will include undervalued and high-growth stocks within the small-cap market. 
  • Low Expense Ratio: The fund’s expense ratio is 0.06%, making it very cost-effective. Therefore, minimal drag on returns will occur. 
  • Stability and Balance: The blending strategy will reduce volatility as the investor diversified across value and growth stocks. 

This fund suits investors seeking a middle ground between value-focused and growth-oriented small-cap funds. It offers steady growth potential without excessive risk. 

Frequently Asked Questions

Know how much risk you can take given your financial goals and investment time horizon. 

  • Diversify portfolio: Invest in asset classes and funds that lower general risk. 
  • Research Thoroughly: Before investing in that fund, know the prior performance of the fund management strategy and check your expense ratio. 
  • Stay disciplined: Avoid decisions made when short-term market movements come into play. 
  • Seek professional Advice: Seek a financial consultant for individualised investment advice. 

The impact of corporate actions, including mergers and acquisitions, stock splits, and declaration of dividends, is enormous on small-cap value funds. For instance, 

  • Mergers and Acquisitions: A large corporation’s takeover of a small-cap company immediately increases the price and the subsequent gain to the fund. 
  • Dividends: Small-cap value funds of firms with stable dividend payments tend to boost the investment’s net return. 
  • Stock Splits: When companies have a stock split, their value does not alter, but they increase liquidity, attracting many more investors to that firm. 

Investment Focus: 

  • Investment in an investor value fund is in undervalued stocks. Sinvest funds invest in companies that can, which may have a relatively high valuation. 

Risk Profile: 

  • Growth funds have a higher risk profile; instead, value funds may be relatively stable for investment. 

Return Prospect: 

  • The value fund would provide stable returns in the long run. On the other hand, a growth fund will give more significant returns with increased risks. 
  • Diversification: This refers to spreading investments in various companies and sectors. 
  • Regular Monitoring: Monitor fund performance and rebalance according to need. 
  • Set Realistic Goals: Understand that small-cap value funds take time to produce significant returns. 
  • Education: Keep abreast of the market trends and economic conditions affecting small-cap stocks. 
  • Expense Ratio: Lower expense ratios are preferred since they reduce the investment cost. 
  • Performance History: Check the fund’s performance history over 1, 3, and 5 years. 
  • Portfolio Composition: Seek diversification across industries and geographies. 
  • Management Team: Experience and reputation of the fund managers in managing the funds 
  • Liquidity: Trade volume will ensure ease of joining and leaving. 

Related Terms

Most Popular Terms

Other Terms

Know More about

Margin Trading

Bond Trading

Securities Lending

Supplementary Retirement Scheme

Money Market Funds

REITs ETF

Singapore Stocks

Opening Investment Account

Forex Trading

Option Trading

CFDs

Buying Unit Trusts

Treasury Bonds

Robo Advisor

Online Investing

Tools/Educational Resources

Sti components

Indices

Bond screener

Market Watch

Morning Note

Thematic portfolio

Economic Calender

Market Journal

Money Talk

Market Call

Stock Research

Fund screener

Etf screener

Investment Seminars

FAQs

Markets Offered by POEMS

SGX

PSE

ASX

KRX

SET

BIST

HNX

HOSE

NYSE

HKX

IDX

LSE

TWSE

FWB

TSE

NYSE

NASDAQ

US Asian Hours

BURSA

China A Shares

China B Shares

Euronext Paris

Euronext Lisbon

Euronext Amsterdam

    Read the Latest Market Journal

    Phillip SING Income ETF Reaches All-Time High Dividend with Banking Sector Focus

    Published on Aug 28, 2026 182 

    Brief Overview Phillip Securities Research maintains an ACCUMULATE recommendation on Phillip SING Income ETF (SINGINC) with an increased target price of S$1.82, up from the previous S$1.59. The ETF has experienced portfolio rebalancing with increased banking sector concentration, while DBS Group and Singapore Exchange remain key holdings alongside new top holding Oversea-Chinese Banking Corporation. The firm remains constructive on SINGINC as its dividend reaches an all-time high, supported by stronger distributions from the portfolio. Investment Positives The primary strength of SINGINC lies in its dividend performance, which has reached an all-time high. This achievement is underpinned by stronger distributions from the portfolio, particularly benefiting from the ETF's large exposure to Singapore banks. The ETF demonstrates strong diversification across six sectors, with financials representing the largest allocation at 44.2% and REITs comprising 21.8% of the portfolio. This diversified approach provides balanced exposure across Singapore's key income-generating sectors. Recent portfolio changes reflect strategic positioning towards Singapore's banking sector. Oversea-Chinese Banking Corporation has become the largest holding at 11.4%, while DBS Group's weight increased slightly from 10.3% to 10.7%. This greater concentration in Singapore's banking sector among the portfolio's largest positions, places the ETF to benefit from the sector's performance. Looking ahead, resilient bank earnings and dividends are expected to continue supporting income generation. Additionally, a more favourable interest-rate environment for REITs should enhance the performance of the ETF's second-largest sector allocation. Outlook Phillip Securities Research maintains a constructive outlook on SINGINC. The combination of resilient bank earnings and dividends, alongside a more favourable interest-rate environment for REITs, should continue supporting income generation. Singapore's market revitalisation initiatives are expected to provide an additional catalyst for performance. Recommendation & Target Price Phillip Securities Research maintains an ACCUMULATE recommendation on Phillip SING Income ETF. The target price has been increased to S$1.82 from the previous S$1.59, derived using equal weightage between historical dividend yield spread valuation (S$2.20) and price-to-earnings ratio valuation (S$1.44). Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

    Phillip Securities Sees Singapore Banks Delivering Robust Performance Despite Margin Pressures

    Published on Aug 28, 2026 50 

    Brief Overview Phillip Securities Research highlights that Singapore interest rates climbed for the third consecutive month in July, with loan growth surpassing 9% year-on-year for the first time since COVID. The firm's second quarter 2026 bank earnings analysis shows performance exceeded expectations, driven by record fee and trading income, despite continued net interest income (NII) declines. The research house maintains its positive stance on the sector while acknowledging mixed guidance updates from major banks. Investment Positives The team identifies several compelling reasons for optimism in Singapore banking. Loan growth has become a significant positive catalyst, crossing the 9% year-on-year threshold for the first time since the pandemic, with June 2026 recording 9.2% growth. This volume of expansion is compensating for what interest margins cannot deliver, representing a fundamental shift in the growth dynamic. Record fee and trading income performance stands out as key earnings drivers. These non-interest revenues more than offset another quarter of declining NII during the second quarter of 2026, with the analyst expecting this trend to continue delivering results through the second half of 2026. CASA deposits demonstrated robust growth of 16% year-on-year, maintaining the CASA ratio at 20.6% of total deposits. This performance is particularly valuable as it keeps funding costs contained despite the challenging interest rate environment. DBS and OCBC have raised their full-year 2026 earnings guidance, signalling management confidence in their business outlook. OCBC specifically increased its loan growth guidance, reinforcing the positive volume of momentum across the sector. The analyst notes that banks' dividend yields remain attractive at 4.0% for FY26e, supported by share buyback programmes and capital return dividends that bolster return on equity. Investment Negatives Net interest margins continue to face pressure, declining 17-22 basis points across the three major banks during the quarter. This margin compression represents an ongoing headwind that volume growth is working to offset rather than eliminate. The Monetary Authority of Singapore's policy tightening on 27 July, which steepened the Singapore dollar NEER appreciation slope to around 1.25% from approximately 1.00%, creates a counteracting force against rising SORA rates. A stronger Singapore dollar works to lower SGD rates, potentially capping the net interest margin recovery rather than reversing the decline. The Monetary Authority of Singapore's policy tightening on 27 July, which steepened the Singapore dollar NEER appreciation slope to around 1.25% from approximately 1.00%, creates a counteracting force against rising SORA rates. A stronger Singapore dollar works to lower SGD rates, potentially capping the net interest margin recovery rather than reversing the decline. UOB reduced its fee growth guidance to low single digits from previously high single digits, indicating some uncertainty around non-interest income sustainability across all institutions. The analyst expects NII to turn positive year-on-year only towards the fourth quarter of 2026, suggesting continued near-term pressure on this core revenue stream. Outlook The research suggests SORA will hold around current levels through the second half of 2026 rather than climb further, limiting the scope for significant margin expansion. However, the combination of strong volume growth and robust non-interest income is expected to support overall earnings momentum. Recommendation & Target Price Phillip Securities Research maintains an ACCUMULATE recommendation on Singapore banks. The firm expresses preference for DBS, citing its fixed dividend per share policy and raised FY26e guidance, and OCBC, highlighting wealth management momentum and remaining capital return potential. No specific target prices are provided in the report. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

    Soilbuild Construction Maintains Strength Despite Project Delays

    Published on Aug 28, 2026 34 

    Brief Overview Soilbuild Construction Group Ltd delivered mixed 1H26 results with revenue and profit below expectations, primarily due to significant delays in precast project recognition. However, the company demonstrated resilience with 25.8% year-on-year profit growth driven by strong construction segment performance and margin expansion, whilst maintaining its dividend appeal through increased payout ratios. Investment Positives The standout positive for TeleChoice centres on the strong momentum in its PCS division. PCS revenue grew an impressive 25% year-on-year in 1H26 to S$205mn, whilst profit before tax spiked 140% to S$6.1mn. This growth was driven by U Mobile's expansion in mobile subscribers, with handset demand receiving additional support from promotional activities and increased subsidies as more consumers transition from prepaid to postpaid plans. Margin performance proved particularly impressive, with 1H26 net margins expanding by 1.9 percentage points year-on-year to 12.3%. This represents an 8.2 percentage point premium over average local peers' net margins of 4.1%, achieved through operational scale benefits and timely project deliveries. The company's balance sheet strength improved markedly, with 1H26 net cash turning positive to S$138 million compared to 1H25 net debt of S$0.6 million. This transformation was driven by 18% year-on-year higher operating cash flow to S$56.5 million, whilst receivables fell S$30.7 million half-on-half, freeing up working capital. Shareholder returns increased substantially through a higher dividend payout ratio. The proposed interim dividend of 1.6 cents per share represents a 2.2 times year-on-year increase from 0.5 cents per share in 1H25. The 1H26 dividend payout ratio increased by 18 percentage points year-on-year, supported by the stronger balance sheet. Investment Negatives Precast segment performance presented challenges, with revenue declining 59% to S$24.2 million due to project recognition delays. Many precast projects remained in the design phase, creating timing differences that impacted overall revenue achievement. Order book size decreased to S$800 million from S$1.19 billion in 1H25, representing a 32.8% decline following progress on major projects with exceptional scale, reducing visibility for future performance. Outlook Production is expected to ramp up in 2H26 and into 1H27 as precast projects advance beyond the design phase. Higher industrial demand is anticipated as 29% more industrial land is released from the Industrial Government Land Sales programme for 2H26. The company is expected to gradually win more tenders and expand its order book size beyond S$1 billion. Recommendation & Target Price Phillip Securities Research maintains a BUY recommendation with an unchanged target price of S$1.20. The valuation multiple was lowered from 9 times to 8.5 times FY27 price-to-earnings ratio to reflect lower visibility from the smaller order book. The company trades at an FY26 dividend yield of approximately 6.2%. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

    UltraGreen.ai – One small step for rival, no giant leap

    Published on Aug 28, 2026 28 

    Brief Overview Zydus Lifesciences announced on 4 Aug 26 that it had secured 180-day Competitive Generic Therapy exclusivity from the FDA for a generic ICG dye, introducing the first credible competitor to UltraGreen.ai's US franchise. UltraGreen.ai's share price dropped 30.7% yesterday following this news. Despite this development, Phillip Securities Research believes the FDA approval for Zydus is not an imminent threat to UltraGreen.ai. Investment Positives Several factors support UltraGreen.ai's defensive position against new competition. The company has established significant operational advantages that will be difficult for new entrants to replicate quickly. UltraGreen.ai has spent years building its current capacity of approximately 3 million vials per year, supported by exclusive evergreen API contracts, dedicated lyophilisation capacity and a multi-contract manufacturing organisation network. The company benefits from established market relationships that new competitors must develop from scratch. New entrants need to establish hospital and group purchasing organisation relationships, whilst hospitals have little incentive to switch from a proven supplier. UltraGreen.ai's competitive moat is reinforced by its focused approach and integrated platform. ICG is the company's sole product focus, unlike diversified generics players such as Zydus Lifesciences. The company's position is further strengthened by its camera and software platform, and by a regulatory dossier built over 15 years. Additionally, the 180-day CGT exclusivity that Zydus has secured actually blocks other generic makers from using the Abbreviated New Drug Application pathway to get approval, limiting future competitors from entering the market for that period. UltraGreen.ai will continue to sell ICG vials in the US during this exclusivity period. Investment Negatives The primary concern is aggressive pricing competition from new entrants. There is a risk that Zydus may compete aggressively on price, undercutting the market significantly to gain market share. This potential pricing pressure has led to reductions in earnings forecasts, with FY26e and FY27e PATMI reduced by 3% and 6% respectively to account for this risk. Outlook Whilst competition has emerged, the analyst believes UltraGreen.ai's established infrastructure and market position provide significant defensive advantages. The company's focused approach to ICG, combined with its integrated platform and long-established regulatory dossier, should help maintain its market position despite new competition. Recommendation & Target Price Phillip Securities Research maintains a BUY recommendation for UltraGreen.ai with a lower DCF-based target price of US$1.81, reduced from the previous US$1.91. The company trades at an FY26e P/E of 9.9x. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

    CNMC Gold Maintains Buy Rating Despite Production Headwinds, Target Price Cut to S$2.03

    Published on Aug 24, 2026 155 

    Phillip Securities Research has maintained its BUY recommendation on CNMC whilst cutting its target price to S$2.03 from S$2.34, as higher gold prices help offset declining production volumes from the company's mining operations. Company Overview CNMC operates gold mining activities with fine gold comprising approximately 76% of its total revenue. The company is currently undertaking a significant US$12 million underground mine construction project at New Found and Manson's Lode, targeted for completion by the end of 2027. Strong Financial Performance Despite Volume Challenges The company demonstrated resilient financial performance in the first half of fiscal 2026, with revenue increasing 23.4% year-on-year to US$65.2 million and profit after tax and minority interests rising 17.8% to US$18.6 million. This growth was primarily driven by a substantial 40% increase in fine gold's average selling price to US$4,486 per ounce. Key Positives Supporting Performance Fine gold revenue, which represents the company's largest revenue stream, surged 31% year-on-year to US$49.8 million despite lower production volumes across all metals. The significant price appreciation in precious metals proved crucial, with gold prices rising 40% and silver prices increasing by an impressive 95% year-on-year. This pricing strength successfully offset the negative impact of reduced mining volumes. The underground mine construction project continues to progress according to schedule, with both the hoisting system and surface infrastructure already completed at New Found and Manson's Lode sites. The next phase involves shaft excavation as part of the comprehensive development programme. Operational Challenges and Revised Outlook However, the company faces production headwinds from lower-grade ore extraction through open-pit mining operations. This has prompted Phillip Securities Research to reduce its fiscal 2026 earnings forecast by 18%, reflecting a 7% reduction in the gold average selling price assumption to US$4,500 per ounce and a 16% decline in expected production volume to 23,957 ounces. The mining operations also contend with higher diesel prices and the challenge of spreading fixed costs over lower output levels, which impacts operational efficiency. CNMC currently trades at 11.7 times forward fiscal 2026 price-to-earnings ratio. The valuation methodology excludes terminal value assumptions, with the analysis based on the mining permit's validity through 2034. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

    United Hampshire US REIT Posts Solid Growth with Strong Defensive Portfolio, Maintains Buy Rating at US$0.69 Target

    Published on Aug 24, 2026 60 

    Strong Half-Year Performance Underpins Income Visibility United Hampshire US REIT (UHREIT), a defensive real estate investment trust focused on grocery, necessity retail, and self-storage properties in the United States, has delivered a solid first-half performance that reinforces its position as an income-focused investment. The REIT reported net property income of US$25.5 million for 1H26, representing a 6.4% year-on-year increase, whilst distribution per unit grew 3.3% to 2.16 US cents. Phillip Securities Research has reiterated its BUY recommendation with an unchanged dividend discount model-based target price of US$0.69, highlighting the trust's strong income visibility and attractive current trading yield. Operational Excellence Drives Performance The company's performance was bolstered by several key operational achievements and strategic acquisitions. New lease commencements, rental escalations, and contributions from recently acquired properties Dover Marketplace and Wallingford Fair Shopping Centre, purchased in August 2025 and January 2026 respectively, drove the distributable income growth. However, this was partially offset by higher finance costs resulting from additional borrowings used to fund these acquisitions. Strong Fundamentals Support Defensive Appeal UHREIT's defensive characteristics remain firmly intact, with grocery and necessity properties maintaining exceptionally high occupancy at 97.6%, demonstrating the resilient nature of essential retail properties. The self-storage segment showed notable improvement, with occupancy rising 430 basis points to 93.5%, driven by the peak spring leasing season. Average quarterly net rental rates remained healthy across the portfolio, with Millburn Self-Storage showing slight increases whilst Carteret Self-Storage rates remained broadly stable. The trust signed 260,000 square feet of leases during the first half at positive rent reversion, underlining strong tenant demand. A significant competitive advantage lies in UHREIT's limited near-term leasing risk, with only 0.6% and 4.6% of grocery and necessity leases expiring in FY26 and FY27 respectively. Improving Financial Metrics Financial management continues to strengthen, with the all-in cost of debt improving to 4.89% from 5.13% year-on-year and expected to decline further to 4.7% in FY26. The trust maintains 71.5% of debt on fixed rates, providing protection against interest rate volatility. Aggregate leverage improved to 40.4% and is projected to decline to approximately 37% following the divestment of BJ's Quincy. UHREIT currently trades at an attractive FY26 estimated dividend yield of 8.8%, supported by a long weighted average lease expiry of 7.9 years and high tenant retention rate of 90%. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

    Centurion Corporation Maintains Strong Growth Trajectory with BUY Rating and S$1.94 Target Price

    Published on Aug 21, 2026 87 

    Centurion Corporation Ltd (CCL), a leading provider of purpose-built worker accommodation (PBWA) and student accommodation across Singapore, Malaysia, Australia, and the UK, has demonstrated robust growth momentum in its 1H26 results. The company operates a diversified portfolio of accommodation assets serving both migrant workers and students across multiple markets. Strong Revenue Growth Driven by Strategic Acquisitions CCL's revenue performance has been particularly impressive, with first-half 2026 revenue surging 31% year-on-year to S$184.9 million, marking the company's strongest growth since the first half of 2022. This exceptional performance was primarily driven by a series of strategic acquisitions and asset enhancement initiatives across key markets. The revenue acceleration reflects several major acquisitions that have significantly expanded CCL's capacity. The company acquired an additional 55% stake in the 8,006-bed Westlite Mandai Purpose-Built Workers' Accommodation (PBWA) facility, representing 19% of Singapore's capacity. In Malaysia, CCL acquired the 7,083-bed Harum Megah PBWA, adding 20% to the country's capacity. The Australian market saw the addition of the 732-bed EPIISOD Macquarie Park facility, which boosted Australia's PBSA capacity by 82%. Beyond acquisitions, ongoing asset enhancement initiatives have contributed substantially to growth. These projects added 5,460 beds, representing a 13% increase in Singapore capacity through expansions at Westlite Toh Guan and Westlite Mandai PBWA facilities, which are currently in the occupancy ramp-up phase. Market Dynamics Signal Continued Demand A significant positive development for CCL came through securing a three-year lease extension from JTC for the 1,224-bed Westlite Tuas Avenue 2 quick build dormitory, with options for an additional 3.5-year extension. This extension indicates a shortage of worker dormitories in Singapore, particularly given the progress of major construction projects including Changi Terminal 5, Marina Bay Sands Integrated Resort, healthcare facilities, and Cross Island Line construction. Investment Outlook and Guidance Phillip Securities Research maintains a BUY recommendation with an upgraded target price of S$1.94, increased from the previous S$1.85. The revised valuation incorporates CCL's 7,000-bed Kranji Close PBWA project and improved quick build dormitory valuations. CCL has provided forward revenue guidance of S$190 million for the second half of 2026, representing 22% year-on-year growth, with total beds expected to grow at a 5% compound annual growth rate through 2028. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

    Frencken Group Outlook Strengthens on Semiconductor Recovery, Upgraded to Buy with S$3.30 Target Price

    Published on Aug 21, 2026 57 

    Frencken Group Ltd, a leading provider of precision engineering and manufacturing services across semiconductor, medical, automotive, and industrial automation sectors, has received an upgraded rating from Phillip Securities Research following its 1H26 results and improved outlook for the remainder of the year. Mixed First Half Performance Sets Stage for Recovery The company's 1H26 revenue and profit after tax and minority interests (PATMI) came in within expectations, representing 47% and 45% of full-year forecasts respectively. PATMI declined 3% year-on-year to S$19.2 million, primarily due to anticipated weakness in semiconductor and analytical life science segments. However, this decline was partially offset by robust performance in medical, industrial automation, and automotive divisions. Key Positive Developments Drive Optimism The medical segment showed particularly strong momentum, with 2Q26 revenue accelerating to 16% year-on-year growth, reaching S$35.8 million compared to just 5% growth in 1Q26. This acceleration was driven by increased orders from Europe for digital pathology equipment, highlighting the company's strong positioning in advanced medical technology manufacturing. Industrial automation also demonstrated resilience, with 2Q26 revenue rebounding 19% year-on-year to S$10.8 million following a 1% decline in 1Q26. This recovery was attributed to higher orders from the company's data storage customer, though management cautioned that 2H26 industrial automation revenue is expected to decline due to changes in customer sourcing arrangements. The automotive segment maintained steady growth momentum, with 1H26 revenue advancing 10% year-on-year to S$32.2 million. This performance was underpinned by increased production of radar antennas. Notably, Frencken's European automotive customer is transitioning from pilot production in Sweden to high-volume production in China, with management guiding a production ramp that will increase volumes quarter-by-quarter over the next two years. Second Half Recovery Expected Phillip Securities Research anticipates 2H26 growth in Frencken's semiconductor, automotive, and medical segments will offset the projected decline in industrial automation. The semiconductor outlook appears particularly promising, with DUV and metrology demand expected to surge for the company's Netherlands front-end semiconductor customer in 2H26. Additionally, some demand pull-in is anticipated from automotive customers. Based on these developments, Phillip Securities Research upgraded Frencken Group to BUY from ACCUMULATE whilst maintaining the target price at S$3.30, representing a valuation of 29x FY27 price-to-earnings ratio. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

    Latest Videos

    Join Events & Seminars

    Learn best practices and latest market outlook from experts and special guests

    Hear & Ask our Experts

    Join live weekly market calls

    Read Popular News & Reports, Technical Pulses

    at www.stocksbnb.com

    Subscribe to our YouTube Channel

    New video every week

    Follow us

    Facebook Social Icon Instagram Icon Twitter Social Icon Youtube Social Icon

    IMPORTANT INFORMATION

    This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

    An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

    Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

    Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

    The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

    The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

    The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

    This advertisement has not been reviewed by the Monetary Authority of Singapore.  

     

    Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
    250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
    Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com